| Maria Pimenova, MD | |
|
1301 Punchbowl St, Honolulu, HI 96813-2402 | |
| (808) 691-1000 | |
| Not Available |
| Full Name | Maria Pimenova |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 1301 Punchbowl St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497371470 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MDR-7956 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria Pimenova, MD 2444 Hihiwai St Apt 1902, Honolulu, HI 96826-5112 Ph: (409) 370-0568 | Maria Pimenova, MD 1301 Punchbowl St, Honolulu, HI 96813-2402 Ph: (808) 691-1000 |
News Archive
Since the COVID 19 pandemic, it has been established that the causative virus, SARS-CoV-2 gains entry to the target host cell via its spike glycoprotein.
St. Jude Children's Research Hospital scientists have used sophisticated pharmacologic modeling and simulation to translate preclinical findings into a successful phase I clinical trial of a chemotherapy agent for treatment of ependymoma. The research marked the first time the approach has been used to calculate drug doses for a clinical trial in pediatric brain tumor patients.
Researchers at UC Irvine and The University of Texas at Arlington have discovered how spinning microparticles can direct the growth of nerve fiber, a discovery that could allow for directed growth of neuronal networks on a chip and improve methods for treating spinal or brain injuries.
The Children's Hospital of Philadelphia (CHOP) and BGI-Shenzhen today announced a formal agreement to collaborate on research into next-generation sequencing and analysis of pediatric brain tumors, in support of the Childhood Brain Tumor Tissue Consortium (CBTTC).
MacroGenics, Inc. and Eli Lilly and Company today announced that the Protege Data Monitoring Committee (DMC), composed of independent experts in the fields of diabetes and biostatistics, has completed a planned analysis of one-year safety and efficacy data of the Protege Phase 3 clinical trial of teplizumab, an investigational biologic under development for the treatment of individuals with recent-onset type 1 diabetes.
› Verified 6 days ago
Stanley Y. Loo, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Sean Saito, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1356 Lusitana St Fl 5, Honolulu, HI 96813 Phone: 808-295-6495 | |
Dr. Christopher Lum, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St, 4th Floor, Honolulu, HI 96813 Phone: 808-547-4271 | |
Janira Marita Navarro Sanchez, MD Pathology Medicare: Medicare Enrolled Practice Location: 1356 Lusitana St Fl 5, Honolulu, HI 96813 Phone: 808-586-8212 | |
Dr. Karen S Thompson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1309 Punahou St., Basement, Honolulu, HI 96826 Phone: 808-983-8581 Fax: 808-973-1401 | |
Dr. Kirk Hirata, Pathology Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St, 4th Floor, Honolulu, HI 96813 Phone: 808-547-4271 | |
Gregory Kiyoshi Kobayashi, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 347 N Kuakini St, Kuakini Medical Center, Honolulu, HI 96817 Phone: 808-547-9496 Fax: 808-547-9497 |